Bangladesh Core FHIR Implementation Guide
0.4.3 - Published by DGHS, MoHFW

Bangladesh Core FHIR Implementation Guide - Published by Ministry of Health and Family Welfare. See the Directory of published versions

## : Bangladesh Medication Dose Form CodeSystem - JSON Representation

Page standards status: Informative | Maturity Level: 1

Raw json | Download

    {
      "resourceType" : "CodeSystem",
      "id" : "bd-dose-form",
      "text" : {
        "status" : "generated",
        "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><div xml:lang=\"en\" lang=\"en\"><hr/><p><b>English</b></p><hr/><p class=\"res-header-id\"><b>Generated Narrative: CodeSystem bd-dose-form</b></p><a name=\"bd-dose-form\"> </a><a name=\"hcbd-dose-form\"> </a><p>This  code system <code>https://fhir.dghs.gov.bd/core/CodeSystem/bd-dose-form</code> defines the following codes:</p><table class=\"codes\"><tr><td style=\"white-space:nowrap\"><b>Code</b></td><td><b>Display</b></td><td><b>Definition</b></td></tr><tr><td style=\"white-space:nowrap\">TAB<a name=\"bd-dose-form-TAB\"> </a></td><td>Tablet</td><td>Solid oral dosage form, usually uncoated or coated, intended for swallowing.</td></tr><tr><td style=\"white-space:nowrap\">DTAB<a name=\"bd-dose-form-DTAB\"> </a></td><td>Dispersible Tablet</td><td>Tablet designed to be dissolved/dispersed in water before administration.</td></tr><tr><td style=\"white-space:nowrap\">CAP<a name=\"bd-dose-form-CAP\"> </a></td><td>Capsule</td><td>Solid dosage form with active ingredients enclosed in a gelatin shell.</td></tr><tr><td style=\"white-space:nowrap\">SYP<a name=\"bd-dose-form-SYP\"> </a></td><td>Syrup</td><td>Liquid oral dosage form containing active substance(s) in solution.</td></tr><tr><td style=\"white-space:nowrap\">SUSP<a name=\"bd-dose-form-SUSP\"> </a></td><td>Suspension</td><td>Liquid oral dosage form with insoluble particles dispersed in a liquid.</td></tr><tr><td style=\"white-space:nowrap\">PFS<a name=\"bd-dose-form-PFS\"> </a></td><td>Powder for Suspension</td><td>Powder that requires reconstitution into a liquid suspension before use.</td></tr><tr><td style=\"white-space:nowrap\">INJ<a name=\"bd-dose-form-INJ\"> </a></td><td>Injection</td><td>Sterile solution or suspension intended for parenteral administration.</td></tr><tr><td style=\"white-space:nowrap\">SOL<a name=\"bd-dose-form-SOL\"> </a></td><td>Solution</td><td>Liquid dosage form where drug is fully dissolved in a solvent.</td></tr><tr><td style=\"white-space:nowrap\">CRM<a name=\"bd-dose-form-CRM\"> </a></td><td>Cream</td><td>Semi-solid topical dosage form containing the drug in an emulsion base.</td></tr><tr><td style=\"white-space:nowrap\">LOT<a name=\"bd-dose-form-LOT\"> </a></td><td>Lotion</td><td>Low-viscosity liquid topical dosage form for external application.</td></tr></table></div><div xml:lang=\"de\" lang=\"de\"><hr/><p><b>German</b></p><hr/><p class=\"res-header-id\"><b>Generated Narrative: CodeSystem bd-dose-form</b></p><a name=\"de-bd-dose-form\"> </a><a name=\"de-hcbd-dose-form\"> </a><p>This  code system <code>https://fhir.dghs.gov.bd/core/CodeSystem/bd-dose-form</code> defines the following codes:</p><table class=\"codes\"><tr><td style=\"white-space:nowrap\"><b>Code</b></td><td><b>Display</b></td><td><b>Definition</b></td></tr><tr><td style=\"white-space:nowrap\">TAB<a name=\"de-bd-dose-form-TAB\"> </a></td><td>Tablet</td><td>Solid oral dosage form, usually uncoated or coated, intended for swallowing.</td></tr><tr><td style=\"white-space:nowrap\">DTAB<a name=\"de-bd-dose-form-DTAB\"> </a></td><td>Dispersible Tablet</td><td>Tablet designed to be dissolved/dispersed in water before administration.</td></tr><tr><td style=\"white-space:nowrap\">CAP<a name=\"de-bd-dose-form-CAP\"> </a></td><td>Capsule</td><td>Solid dosage form with active ingredients enclosed in a gelatin shell.</td></tr><tr><td style=\"white-space:nowrap\">SYP<a name=\"de-bd-dose-form-SYP\"> </a></td><td>Syrup</td><td>Liquid oral dosage form containing active substance(s) in solution.</td></tr><tr><td style=\"white-space:nowrap\">SUSP<a name=\"de-bd-dose-form-SUSP\"> </a></td><td>Suspension</td><td>Liquid oral dosage form with insoluble particles dispersed in a liquid.</td></tr><tr><td style=\"white-space:nowrap\">PFS<a name=\"de-bd-dose-form-PFS\"> </a></td><td>Powder for Suspension</td><td>Powder that requires reconstitution into a liquid suspension before use.</td></tr><tr><td style=\"white-space:nowrap\">INJ<a name=\"de-bd-dose-form-INJ\"> </a></td><td>Injection</td><td>Sterile solution or suspension intended for parenteral administration.</td></tr><tr><td style=\"white-space:nowrap\">SOL<a name=\"de-bd-dose-form-SOL\"> </a></td><td>Solution</td><td>Liquid dosage form where drug is fully dissolved in a solvent.</td></tr><tr><td style=\"white-space:nowrap\">CRM<a name=\"de-bd-dose-form-CRM\"> </a></td><td>Cream</td><td>Semi-solid topical dosage form containing the drug in an emulsion base.</td></tr><tr><td style=\"white-space:nowrap\">LOT<a name=\"de-bd-dose-form-LOT\"> </a></td><td>Lotion</td><td>Low-viscosity liquid topical dosage form for external application.</td></tr></table></div><div xml:lang=\"fr\" lang=\"fr\"><hr/><p><b>French</b></p><hr/><p class=\"res-header-id\"><b>Narratif généré : CodeSystem bd-dose-form</b></p><a name=\"fr-bd-dose-form\"> </a><a name=\"fr-hcbd-dose-form\"> </a><p>This  code system <code>https://fhir.dghs.gov.bd/core/CodeSystem/bd-dose-form</code> defines the following codes:</p><table class=\"codes\"><tr><td style=\"white-space:nowrap\"><b>Code</b></td><td><b>Affichage</b></td><td><b>Définition</b></td></tr><tr><td style=\"white-space:nowrap\">TAB<a name=\"fr-bd-dose-form-TAB\"> </a></td><td>Tablet</td><td>Solid oral dosage form, usually uncoated or coated, intended for swallowing.</td></tr><tr><td style=\"white-space:nowrap\">DTAB<a name=\"fr-bd-dose-form-DTAB\"> </a></td><td>Dispersible Tablet</td><td>Tablet designed to be dissolved/dispersed in water before administration.</td></tr><tr><td style=\"white-space:nowrap\">CAP<a name=\"fr-bd-dose-form-CAP\"> </a></td><td>Capsule</td><td>Solid dosage form with active ingredients enclosed in a gelatin shell.</td></tr><tr><td style=\"white-space:nowrap\">SYP<a name=\"fr-bd-dose-form-SYP\"> </a></td><td>Syrup</td><td>Liquid oral dosage form containing active substance(s) in solution.</td></tr><tr><td style=\"white-space:nowrap\">SUSP<a name=\"fr-bd-dose-form-SUSP\"> </a></td><td>Suspension</td><td>Liquid oral dosage form with insoluble particles dispersed in a liquid.</td></tr><tr><td style=\"white-space:nowrap\">PFS<a name=\"fr-bd-dose-form-PFS\"> </a></td><td>Powder for Suspension</td><td>Powder that requires reconstitution into a liquid suspension before use.</td></tr><tr><td style=\"white-space:nowrap\">INJ<a name=\"fr-bd-dose-form-INJ\"> </a></td><td>Injection</td><td>Sterile solution or suspension intended for parenteral administration.</td></tr><tr><td style=\"white-space:nowrap\">SOL<a name=\"fr-bd-dose-form-SOL\"> </a></td><td>Solution</td><td>Liquid dosage form where drug is fully dissolved in a solvent.</td></tr><tr><td style=\"white-space:nowrap\">CRM<a name=\"fr-bd-dose-form-CRM\"> </a></td><td>Cream</td><td>Semi-solid topical dosage form containing the drug in an emulsion base.</td></tr><tr><td style=\"white-space:nowrap\">LOT<a name=\"fr-bd-dose-form-LOT\"> </a></td><td>Lotion</td><td>Low-viscosity liquid topical dosage form for external application.</td></tr></table></div></div>"
      },
      "extension" : [
        {
          "url" : "http://hl7.org/fhir/StructureDefinition/structuredefinition-fmm",
          "valueInteger" : 1,
          "_valueInteger" : {
            "extension" : [
              {
                "url" : "http://hl7.org/fhir/StructureDefinition/structuredefinition-conformance-derivedFrom",
                "valueCanonical" : "https://fhir.dghs.gov.bd/core/ImplementationGuide/bd.fhir.core"
              }
            ]
          }
        },
        {
          "url" : "http://hl7.org/fhir/StructureDefinition/structuredefinition-standards-status",
          "valueCode" : "informative",
          "_valueCode" : {
            "extension" : [
              {
                "url" : "http://hl7.org/fhir/StructureDefinition/structuredefinition-conformance-derivedFrom",
                "valueCanonical" : "https://fhir.dghs.gov.bd/core/ImplementationGuide/bd.fhir.core"
              }
            ]
          }
        }
      ],
      "url" : "https://fhir.dghs.gov.bd/core/CodeSystem/bd-dose-form",
      "version" : "0.4.3",
      "name" : "BDMedicationDoseForm",
      "title" : "Bangladesh Medication Dose Form CodeSystem",
      "status" : "draft",
      "date" : "2026-04-10T17:10:06+00:00",
      "publisher" : "Directorate General of Health Services (DGHS), Bangladesh",
      "contact" : [
        {
          "telecom" : [
            {
              "system" : "url",
              "value" : "http://dghs.gov.bd"
            }
          ]
        }
      ],
      "description" : "Medication dose form codes according to CCDS guideline",
      "jurisdiction" : [
        {
          "coding" : [
            {
              "system" : "urn:iso:std:iso:3166",
              "code" : "050"
            }
          ]
        }
      ],
      "content" : "complete",
      "count" : 10,
      "concept" : [
        {
          "code" : "TAB",
          "display" : "Tablet",
          "definition" : "Solid oral dosage form, usually uncoated or coated, intended for swallowing."
        },
        {
          "code" : "DTAB",
          "display" : "Dispersible Tablet",
          "definition" : "Tablet designed to be dissolved/dispersed in water before administration."
        },
        {
          "code" : "CAP",
          "display" : "Capsule",
          "definition" : "Solid dosage form with active ingredients enclosed in a gelatin shell."
        },
        {
          "code" : "SYP",
          "display" : "Syrup",
          "definition" : "Liquid oral dosage form containing active substance(s) in solution."
        },
        {
          "code" : "SUSP",
          "display" : "Suspension",
          "definition" : "Liquid oral dosage form with insoluble particles dispersed in a liquid."
        },
        {
          "code" : "PFS",
          "display" : "Powder for Suspension",
          "definition" : "Powder that requires reconstitution into a liquid suspension before use."
        },
        {
          "code" : "INJ",
          "display" : "Injection",
          "definition" : "Sterile solution or suspension intended for parenteral administration."
        },
        {
          "code" : "SOL",
          "display" : "Solution",
          "definition" : "Liquid dosage form where drug is fully dissolved in a solvent."
        },
        {
          "code" : "CRM",
          "display" : "Cream",
          "definition" : "Semi-solid topical dosage form containing the drug in an emulsion base."
        },
        {
          "code" : "LOT",
          "display" : "Lotion",
          "definition" : "Low-viscosity liquid topical dosage form for external application."
        }
      ]
    }